TY - JOUR
T1 - The GluN1/GluN2B NMDA receptor and metabotropic glutamate receptor 1 negative allosteric modulator has enhanced neuroprotection in a rat subarachnoid hemorrhage model
AU - Zhang, Zongyong
AU - Liu, Junke
AU - Fan, Cundong
AU - Mao, Leilei
AU - Xie, Rongxia
AU - Wang, Suyun
AU - Yang, Mingfeng
AU - Yuan, Hui
AU - Yang, Xiaoyi
AU - Sun, Jingyi
AU - Wang, Jian
AU - Kong, Jiming
AU - Huang, Siluo
AU - Sun, Baoliang
N1 - Publisher Copyright:
© 2017 Elsevier Inc.
PY - 2018/3
Y1 - 2018/3
N2 - Excessive glutamate in cerebrospinal fluid after subarachnoid hemorrhage (SAH) causes excitotoxic damage through calcium overloading and a subsequent apoptotic cascade. GluN1/GluN2B containing N-methyl-Daspartate (NMDA) receptor and metabotropic glutamate receptor 1 (mGluR1) can play a leading role in glutamate-mediated excitotoxicity. Here we report that Ifenprodil (100 μM), a negative allosteric modulator (NAM) of GluN1/GluN2B NMDA receptors, and JNJ16259685 (10 μM), a NAM of mGluR1, have an additive efficacy against glutamate (100 μM)-induced Ca2 + release and cell apoptosis in primary cortical, hippocampal, and cerebellar granule neurons. Compared with intraperitoneal injection of Ifenprodil (10 mg/kg) and JNJ16259685 (1 mg/kg) separately, the combination therapy of Ifenprodil plus JNJ16259685 significantly improves the neurological deficit at 24 h and 72 h after experimental SAH. It reduces the number of TUNEL/DAPI-positive and activated caspase-3/NeuN-positive cells in cortical and hippocampal CA1 regions at 72 h, decreases levels of glutamate in cerebrospinal fluid at 72 h, and reduces the mitochondrial Ca2 + concentration. Meanwhile, the combination therapy attenuates apoptosis as shown by an increased Bcl-2 expression, decreased Bax expression and release of cytochrome c, and reduction of cleaved caspase-9 and caspase-3 at 24 h after SAH. These findings indicate that targeting both the intracellular Ca2 + overloading and neuronal apoptosis using the Ifenprodil and JNJ16259685 is a promising new therapy for SAH.
AB - Excessive glutamate in cerebrospinal fluid after subarachnoid hemorrhage (SAH) causes excitotoxic damage through calcium overloading and a subsequent apoptotic cascade. GluN1/GluN2B containing N-methyl-Daspartate (NMDA) receptor and metabotropic glutamate receptor 1 (mGluR1) can play a leading role in glutamate-mediated excitotoxicity. Here we report that Ifenprodil (100 μM), a negative allosteric modulator (NAM) of GluN1/GluN2B NMDA receptors, and JNJ16259685 (10 μM), a NAM of mGluR1, have an additive efficacy against glutamate (100 μM)-induced Ca2 + release and cell apoptosis in primary cortical, hippocampal, and cerebellar granule neurons. Compared with intraperitoneal injection of Ifenprodil (10 mg/kg) and JNJ16259685 (1 mg/kg) separately, the combination therapy of Ifenprodil plus JNJ16259685 significantly improves the neurological deficit at 24 h and 72 h after experimental SAH. It reduces the number of TUNEL/DAPI-positive and activated caspase-3/NeuN-positive cells in cortical and hippocampal CA1 regions at 72 h, decreases levels of glutamate in cerebrospinal fluid at 72 h, and reduces the mitochondrial Ca2 + concentration. Meanwhile, the combination therapy attenuates apoptosis as shown by an increased Bcl-2 expression, decreased Bax expression and release of cytochrome c, and reduction of cleaved caspase-9 and caspase-3 at 24 h after SAH. These findings indicate that targeting both the intracellular Ca2 + overloading and neuronal apoptosis using the Ifenprodil and JNJ16259685 is a promising new therapy for SAH.
KW - Ca overloading
KW - Glutamate excitotoxicity
KW - Ifenprodil
KW - JNJ16259685
KW - Subarachnoid hemorrhage
UR - http://www.scopus.com/inward/record.url?scp=85038830186&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85038830186&partnerID=8YFLogxK
U2 - 10.1016/j.expneurol.2017.12.005
DO - 10.1016/j.expneurol.2017.12.005
M3 - Article
C2 - 29258835
AN - SCOPUS:85038830186
SN - 0014-4886
VL - 301
SP - 13
EP - 25
JO - Experimental Neurology
JF - Experimental Neurology
ER -